CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for ...
US-based OnCusp Therapeutics has reported initial Phase Ia data from its ongoing multicentre dose escalation and expansion Phase I trial of the cadherin-6 (CDH6)-directed antibody-drug conjugate (ADC) ...
A Phase II manufacturing process that used a high titre antibody fragment secreting, high-cell-density E. coli expression system and Upfront’s 2nd Generation EBA chromatography resulted in a 60% ...
TotalEnergies has started construction of an initial gas treating unit as part of the larger gas processing plant under the first-phase development of the Gas Growth Integrated Project aimed at ...
Add articles to your saved list and come back to them any time. Sarytogan Graphite has passed another milestone in the development of its high-quality graphite project in Kazakhstan by securing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback